Ausgabe 3/2017
Cancer and Autoimmunity
Inhalt (10 Artikel)
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer
William C. Watt, Denise L. Cecil, Mary L. Disis
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses
David Schrama, Cathrin Ritter, Jürgen C. Becker
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, Mariusz A. Wasik, Ivan V. Litvinov, Lars Iversen, Erik Langhoff, Anders Woetmann, Niels Odum
Potential importance of B cells in aging and aging-associated neurodegenerative diseases
Arya Biragyn, Maria Aliseychik, Evgeny Rogaev
Myeloid-derived suppressor cells and tumor escape from immune surveillance
Viktor Umansky, Carolin Blattner, Viktor Fleming, Xiaoying Hu, Christoffer Gebhardt, Peter Altevogt, Jochen Utikal
Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
Franck Carbonnel, Emilie Soularue, Clélia Coutzac, Nathalie Chaput, Christine Mateus, Patricia Lepage, Caroline Robert
Cancer immunotherapy in patients with preexisting autoimmune disorders
Marco Donia, Magnus Pedersen, Inge Marie Svane